MX2021000380A - Tecnicas de inyeccion para el tratamiento de la celulitis. - Google Patents

Tecnicas de inyeccion para el tratamiento de la celulitis.

Info

Publication number
MX2021000380A
MX2021000380A MX2021000380A MX2021000380A MX2021000380A MX 2021000380 A MX2021000380 A MX 2021000380A MX 2021000380 A MX2021000380 A MX 2021000380A MX 2021000380 A MX2021000380 A MX 2021000380A MX 2021000380 A MX2021000380 A MX 2021000380A
Authority
MX
Mexico
Prior art keywords
cellulite
treatment
injection techniques
buttock
collagenase
Prior art date
Application number
MX2021000380A
Other languages
English (en)
Inventor
Michael Mclane
Saji Vijayan
Matthew W Davis
George Omburo
Todd Kirby
Original Assignee
Endo Global Aesthetics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endo Global Aesthetics Ltd filed Critical Endo Global Aesthetics Ltd
Priority claimed from PCT/IB2019/000777 external-priority patent/WO2020021332A2/en
Publication of MX2021000380A publication Critical patent/MX2021000380A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/91—Injection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente divulgación se refiere a un método para tratar la celulitis en un muslo o glúteo en un sujeto humano mediante la administración de una cantidad eficaz de colagenasa, y después evaluar la reducción de la gravedad de la celulitis por una o más escalas.
MX2021000380A 2018-07-12 2019-07-12 Tecnicas de inyeccion para el tratamiento de la celulitis. MX2021000380A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862697376P 2018-07-12 2018-07-12
US201862733046P 2018-09-18 2018-09-18
PCT/IB2019/000767 WO2020021330A2 (en) 2018-07-12 2019-07-11 Injection techniques for the treatment of cellulite
PCT/IB2019/000777 WO2020021332A2 (en) 2018-07-12 2019-07-12 Injection techniques for the treatment of cellulite

Publications (1)

Publication Number Publication Date
MX2021000380A true MX2021000380A (es) 2021-05-12

Family

ID=68281764

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021000380A MX2021000380A (es) 2018-07-12 2019-07-12 Tecnicas de inyeccion para el tratamiento de la celulitis.

Country Status (11)

Country Link
US (1) US20210187084A1 (es)
EP (1) EP3820437A2 (es)
JP (1) JP2021532177A (es)
KR (1) KR20210068390A (es)
CN (1) CN112996484A (es)
AU (1) AU2019309324A1 (es)
BR (1) BR112021000432A2 (es)
CA (1) CA3106065A1 (es)
IL (1) IL280066A (es)
MX (1) MX2021000380A (es)
WO (1) WO2020021330A2 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023218384A1 (en) * 2022-05-10 2023-11-16 Endo Global Aesthetics Limited Methods of reducing collagenase-mediated bruising in a subject having cellulite

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030152612A1 (en) * 2002-01-03 2003-08-14 Pugliese Peter T. Method and article to control cellulite
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
EP1951305A1 (en) * 2005-11-22 2008-08-06 Wyeth a Corporation of the State of Delaware Immunoglobulin fusion protein formulations
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
MX2014004792A (es) * 2011-10-21 2015-08-14 Auxilium Int Holdings Inc Metodo de tratamiento o reduccion de efp.
ES2740499T3 (es) 2012-01-12 2020-02-05 Endo Global Ventures Enzima de Clostridium histolyticum
ES2855423T3 (es) 2013-03-15 2021-09-23 Biospecifics Tech Corporation Método de tratamiento y producto para fibromas uterinos que utiliza colagenasa purificada
EP3286695A1 (en) 2015-04-24 2018-02-28 Canfield Scientific, Incorporated Dermatological feature tracking over multiple images
BR112019006907A2 (pt) * 2016-10-07 2019-07-02 Regeneron Pharma proteína liofilizada estável em temperatura ambiente
EP3559741B1 (en) 2016-12-22 2021-09-22 Cherry Imaging Ltd Three-dimensional image reconstruction using multi-layer data acquisition
EP3559740A4 (en) 2016-12-22 2020-09-09 EVA - Esthetic Visual Analytics Ltd. REAL-TIME TRACKING FOR THREE-DIMENSIONAL IMAGING
CN115969318A (zh) 2017-03-01 2023-04-18 恩多风投有限公司 用于评估和治疗橘皮组织的装置和方法
MX2019011574A (es) 2017-03-28 2019-12-19 Endo Ventures Ltd Método mejorado para producir aplicaciones relacionadas con la colagenasa.
WO2019023402A1 (en) 2017-07-26 2019-01-31 Canfield Scientific, Incorporated METHOD AND APPARATUS FOR AUTOMATIC GENERATION AND MONITORING OF NORMALIZED ANATOMICAL REGIONS

Also Published As

Publication number Publication date
JP2021532177A (ja) 2021-11-25
KR20210068390A (ko) 2021-06-09
CN112996484A (zh) 2021-06-18
WO2020021330A2 (en) 2020-01-30
WO2020021330A3 (en) 2020-03-12
AU2019309324A1 (en) 2021-02-04
CA3106065A1 (en) 2020-01-30
EP3820437A2 (en) 2021-05-19
IL280066A (en) 2021-03-01
US20210187084A1 (en) 2021-06-24
BR112021000432A2 (pt) 2021-04-06

Similar Documents

Publication Publication Date Title
MX2023008072A (es) Metodo para la evaluacion y el tratamiento de la celulitis.
MX2019012032A (es) Tratamiento de tumores positivos a gen 3 de activacion de linfocitos (lag-3).
ES2692773T3 (es) Tratamientos para la fibrosis
MX2021004828A (es) Uso de antagonistas contra muerte programada 1 (pd-1) y ligando de muerte programada 1 (pd-l1) en combinacion con radioterapia.
MX2016017288A (es) Metodos para tratar el cancer con inhibidores de tigit y agentes contra el cancer.
MX2018001842A (es) Composiciones que incluyen extractos de ampelopsis grossedentata y albizia julibrissin y métodos para uso.
MX2020005547A (es) Moduladores de la actividad del complemento.
WO2019006005A3 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF MELANOMA
PH12020551427A1 (en) Epinephrine spray formulations
ZA201903226B (en) Composition for promoting differentiation of and protecting neural stem cells and method for inducing neural regeneration using same
MX2020011817A (es) Metodos para tratar el linfoma.
MX2021013354A (es) Metodos para tratar y/o prevenir queratosis actinica.
MX2019003703A (es) Método seguro y eficaz para tratar la psoriasis con el anticuerpo específico anti-il23.
MX2018008855A (es) Composicion que comprende toxina botulinica.
MX2019013862A (es) Terapia de combinacion.
MX2023000187A (es) Dosificacion de vibegron para el tratamiento de vejiga sobreactiva.
MX2020010269A (es) Un anticuerpo anti-il-23p 19 (mirikizumab) para usarse en el tratamiento de la colitis ulcerosa.
MX2021013901A (es) Composiciones y métodos para el tratamiento del cáncer.
MX2021005646A (es) Métodos de tratamiento de cáncer con agentes de unión a tubulina.
MX2015010296A (es) Tratamiento de formas progresivas de esclerosis multiple con laquinimod.
MX2017010654A (es) Oxabicicloheptanos y oxabicicloheptenos para el tratamiento de trastornos depresivos y de estres.
MX2021000380A (es) Tecnicas de inyeccion para el tratamiento de la celulitis.
MX2021004709A (es) Metodo y medicamento para tratar cancer insensible a inhibidor de se?alizacion de pd-1/pd-l1.
MX2021003154A (es) Composiciones y métodos para tratar celulitis.
MX2020001428A (es) Composiciones de grapiprant y metodos para usar las mismas.